Figures below are as of 20 Aug 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹240 |
| Estimated listing gain | +24.3% |
| Estimated listing price | ₹1228 |
| Issue price | ₹988 |
| Issue size | ₹1757.00 Cr |
| Open date | 24 Aug 2026 |
| Close date | 27 Aug 2026 |
| Listing date | 01 Sep 2026 |
| Listing at | BSE, NSE |
| IPO type | Mainboard IPO |
| Registrar | MUFG Intime India Pvt.Ltd. |
As of 20 Aug 2026, the grey market premium (GMP) for the Symbiotec Pharmalab Ltd. IPO is ₹240, implying an estimated listing gain of about +24.3% and an estimated listing price near ₹1228. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Symbiotec Pharmalab Ltd. IPO is open for subscription from 24 Aug 2026 to 27 Aug 2026. It is expected to list on 01 Sep 2026.
The Symbiotec Pharmalab Ltd. IPO is priced at ₹988 per share, with a total issue size of ₹1757.00 Cr.